New CFO For SVA Brings Promising Outlook

Sinovac Biotech, Ltd. (NASDAQ: SVA) appoints new CFO Jacob Ho, whose experience and credibility should help to increase investor confidence.

In a research report PiperJaffray writes, "We spoke to SVA's newly hired CFO, Jacob Ho, and believe his experience, credibility, and communication skills is are valuable additions to SVA's management team and could provide investors with additional confidence in the company's financial reporting and corporate communication capabilities. As a reminder, Jacob has over 12 years of accounting and financial reporting experience and previously served as a Senior Manager in Deloitte Beijing office and as a Manager in PWC Beijing office. Prior to his experience in Asia, he held positions at both Deloitte and PWC and implemented compliance programs at U.S. companies. We are impressed with his level of understanding of the SVA business after less than a month of tenure, and believe a full-time CFO will greatly facilitate communications and improve investors' understanding of SVA."